WeVote
Log In

Bill

Bill

HB 3129

Relating to the behavioral health workforce; declaring an emergency.

2025 Regular Session Introduced by Lew Frederick and 8 co-sponsors

HB 3129 moves kratom alkaloids mitragynine and 7-hydroxymitragynine into Schedule III under Illinois' Controlled Substances Act, repealing the Kratom Control Act.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · HB 3129

Summary — HB 3129 (KRATOM — SCHEDULE III)

Status: Introduced (House Bill). Introduced Feb 18–20, 2025 by Rep. William E. Hauter; added co‑sponsor Rep. Patrick Windhorst (6/10/2025). Companion bill: SB 384. Key committee actions and hearings occurred March–April 2025; reported favorably and placed on calendars; as of 4/29/2025 the bill was placed on the General State Calendar and laid on the table subject to call.

Main purpose

HB 3129 amends the Illinois Controlled Substances Act to add the kratom alkaloids mitragynine and 7‑hydroxymitragynine to Schedule III, and repeals the separate Kratom Control Act (720 ILCS 642). The bill moves regulation of these substances into the State’s controlled substances scheduling framework.

Key provisions

  • Amends 720 ILCS 570/208 (Schedule III) to explicitly list:
    • (i) Mitragynine
    • (j) 7‑hydroxymitragynine
  • Repeals the Kratom Control Act (720 ILCS 642), removing that statute from Illinois law.
  • Leaves other Schedule III text intact, and retains an administrative rulemaking provision (existing subsection (h)) allowing the Department to except certain preparations by rule.

Effected persons and entities

  • Consumers: Possession or distribution of products that contain mitragynine or 7‑hydroxymitragynine would be governed by Illinois’ Controlled Substances Act (i.e., treated as Schedule III substances under state law).
  • Retailers, manufacturers, distributors: Businesses that currently sell kratom products would need to comply with Schedule III controls under the State CSA; this could affect manufacturing, labeling, sale, and distribution practices.
  • Law enforcement and courts: Enforcement, prosecution, and sentencing for offenses involving these substances would proceed under the Controlled Substances Act provisions applicable to Schedule III substances.
  • Health care providers and researchers: Use, prescribing (if any), possession for research, and handling of these substances would be subject to Schedule III regulations and any applicable licensing/registration requirements under state law.

Regulatory and legal implications

  • Repeal of the Kratom Control Act consolidates kratom regulation into the general controlled substances framework rather than keeping it under a separate statute.
  • The bill does not itself set new penalty levels; rather, Schedule III classification subjects the substances to existing CSA controls, criminal offenses, and administrative requirements tied to that schedule.
  • Further legislative or administrative action (passage by both chambers and governor’s signature; any Department rulemaking) would be required to finalize implementation.

Procedural notes / next steps

  • Companion SB 384 should be tracked for parallel action in the Senate.
  • For HB 3129 to become law it must pass both chambers and be enacted by the Governor; administrative rulemaking may follow to clarify exemptions or specific regulatory details.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.